Bellevue Life Sciences Acquisition Corp.(BLACU) - 2023 Q2 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ BELLEVUE LIFE SCIENCES ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | --- | --- | |-------------------------- ...